Watch on Radcliffe Vascular:
Dr Marianne Brodmann (Medical University of Graz, AT) joins us at LINC 2022 to discuss the 5-year outcomes stratified according to gender and diabetes status in the IN.PACT Global Study.
TheIN.PACT Global Study assessed the safety and efficacy data on the IN.PACT Admiral™ Drug Eluting Balloon (DEB) (Medtronic) in treatment of atherosclerotic disease .
Discussion Points:
1. Study Background
2. IN.PACT™ AV Access Drug Coated Balloon
3. Key Results in Patients With Diabetes
4. Take-Home Messages
Recorded on-site at LINC, Leipzig, 2022.
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.